A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia
ELVN-001-101
Phase 1 other active
Quick answer
A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia for Chronic myeloid leukemia is a Phase 1 program (other) at Enliven Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Enliven Therapeutics
- Indication
- Chronic myeloid leukemia
- Phase
- Phase 1
- Modality
- other
- Status
- active